Ismael Ghanem Cañete - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

JACC. Case Reports|November 28, 2025

Mavacamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy During Active ChemotherapyJuan Caro-Codón, Silvia Valbuena-López, Ismael Ghanem Cañete, et al.

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 7, 2026

SEOM-GEMCAD-TTD clinical guidelines for anal cancer (2025)Mónica Guillot Morales, Ana Fernández Montes, Julen Fernández-Plana, et al.

Breast Cancer Research and Treatment|March 13, 2013

RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancerAlvaro Moreno-Aspitia, Amylou C Dueck, Ismael Ghanem-Cañete, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

JACC. Case Reports|November 28, 2025

Mavacamten for Symptomatic Obstructive Hypertrophic Cardiomyopathy During Active ChemotherapyJuan Caro-Codón, Silvia Valbuena-López, Ismael Ghanem Cañete, et al.

Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 7, 2026

SEOM-GEMCAD-TTD clinical guidelines for anal cancer (2025)Mónica Guillot Morales, Ana Fernández Montes, Julen Fernández-Plana, et al.

Breast Cancer Research and Treatment|March 13, 2013

RC0639: phase II study of paclitaxel, trastuzumab, and lapatinib as adjuvant therapy for early stage HER2-positive breast cancerAlvaro Moreno-Aspitia, Amylou C Dueck, Ismael Ghanem-Cañete, et al.

Pageof 1